TSX:BU

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Burcon NutraScience

Executive Summary

Burcon NutraScience Corporation, together with its subsidiary, develops plant proteins and ingredients for use in the food and beverage industries in Canada. More Details


Snowflake Analysis

High growth potential with adequate balance sheet.

Share Price & News

How has Burcon NutraScience's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BU's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-9.3%

BU

3.9%

CA Chemicals

-1.0%

CA Market


1 Year Return

144.3%

BU

-13.4%

CA Chemicals

-4.3%

CA Market

Return vs Industry: BU exceeded the Canadian Chemicals industry which returned -15.4% over the past year.

Return vs Market: BU exceeded the Canadian Market which returned -4.2% over the past year.


Shareholder returns

BUIndustryMarket
7 Day-9.3%3.9%-1.0%
30 Day-20.1%4.5%1.3%
90 Day15.6%23.3%1.9%
1 Year144.3%144.3%-9.1%-13.4%-0.9%-4.3%
3 Year207.1%207.1%-30.6%-38.2%6.4%-4.0%
5 Year-9.7%-9.7%-13.7%-28.8%33.3%12.8%

Price Volatility Vs. Market

How volatile is Burcon NutraScience's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Burcon NutraScience undervalued compared to its fair value and its price relative to the market?

9.41x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: BU (CA$2.15) is trading above our estimate of fair value (CA$0.93)

Significantly Below Fair Value: BU is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: BU is unprofitable, so we can't compare its PE Ratio to the CA Chemicals industry average.

PE vs Market: BU is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BU's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BU is overvalued based on its PB Ratio (9.4x) compared to the CA Chemicals industry average (2.3x).


Next Steps

Future Growth

How is Burcon NutraScience forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

68.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BU is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.7%).

Earnings vs Market: BU is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BU's is expected to become profitable in the next 3 years.

Revenue vs Market: BU's revenue (54.6% per year) is forecast to grow faster than the Canadian market (5.8% per year).

High Growth Revenue: BU's revenue (54.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BU's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Burcon NutraScience performed over the past 5 years?

9.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BU is currently unprofitable.

Growing Profit Margin: BU is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: BU is unprofitable, but has reduced losses over the past 5 years at a rate of 9.1% per year.

Accelerating Growth: Unable to compare BU's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BU is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-17.5%).


Return on Equity

High ROE: BU has a negative Return on Equity (-21.05%), as it is currently unprofitable.


Next Steps

Financial Health

How is Burcon NutraScience's financial position?


Financial Position Analysis

Short Term Liabilities: BU's short term assets (CA$13.7M) exceed its short term liabilities (CA$1.3M).

Long Term Liabilities: BU's short term assets (CA$13.7M) exceed its long term liabilities (CA$6.3M).


Debt to Equity History and Analysis

Debt Level: BU's debt to equity ratio (27.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if BU's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BU has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: BU has less than a year of cash runway if free cash flow continues to grow at historical rates of 5.8% each year.


Next Steps

Dividend

What is Burcon NutraScience current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BU's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BU's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BU's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.1yrs

Average management tenure


CEO

Johann Tergesen (57 yo)

1.75yrs

Tenure

CA$369,034

Compensation

Mr. Johann Franz Tergesen, MBA, CPA, CA, serves as the President of Burcon NutraScience Corporation (formerly Burcon Capital Corp.) since September 2000 and serves as the Chief Executive Officer since Janu ...


CEO Compensation Analysis

Compensation vs Market: Johann's total compensation ($USD281.00K) is below average for companies of similar size in the Canadian market ($USD624.31K).

Compensation vs Earnings: Johann's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Johann Tergesen
President & CEO1.75yrsCA$369.03k3.25%
CA$ 7.4m
Jade Cheng
CFO & Treasurerno dataCA$271.03k0.43%
CA$ 979.0k
Martin Schweizer
Vice President of Technical Development11.08yrsCA$218.00k0.16%
CA$ 364.4k
Kam Law
Senior VP of Legal & Corporate Secretary11.08yrsCA$223.83k0.55%
CA$ 1.3m
Randy Willardsen
Senior Vice President of Process18.92yrsCA$287.88k0.72%
CA$ 1.6m

11.1yrs

Average Tenure

Experienced Management: BU's management team is seasoned and experienced (11.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Paul Westdal
Director Emeritusno dataCA$48.72kno data
Mei Wah Chau
Director21.92yrsCA$60.22k0.80%
CA$ 1.8m
John Gilpin
Independent Director9.08yrsCA$79.29kno data
David Lorne Tyrrell
Independent Chairman1.75yrsCA$92.36k0.19%
CA$ 440.0k
Alan Chan
Director10.5yrsCA$57.22kno data
Peter Kappel
Independent Director4.75yrsCA$117.75k0.90%
CA$ 2.1m
David Ju
Independent Director2.83yrsCA$60.97kno data
Chi Leung Ng
Director1.25yrsCA$53.47kno data
Debora Fang
Independent Director0.25yrno datano data

3.8yrs

Average Tenure

77yo

Average Age

Experienced Board: BU's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: BU insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.4%.


Top Shareholders

Company Information

Burcon NutraScience Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Burcon NutraScience Corporation
  • Ticker: BU
  • Exchange: TSX
  • Founded: 1998
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: CA$228.340m
  • Shares outstanding: 106.20m
  • Website: https://www.burcon.ca

Number of Employees


Location

  • Burcon NutraScience Corporation
  • 1946 West Broadway
  • Vancouver
  • British Columbia
  • V6J 1Z2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BUTSX (The Toronto Stock Exchange)YesCommon SharesCACADFeb 1999
BNEDB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 1999
BURO.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 1999

Biography

Burcon NutraScience Corporation, together with its subsidiary, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company’s products include CLARISOY, a soy ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/22 00:04
End of Day Share Price2020/10/21 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.